Coloplast As ADR (CLPBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,066,468 | 1,064,328 | 970,961 | 938,806 | 989,109 |
| Depreciation Amortization | 215,189 | 187,566 | 153,295 | 135,594 | 127,274 |
| Accounts receivable | -5,332 | -73,572 | -56,213 | -51,176 | -37,765 |
| Accounts payable and accrued liabilities | -29,472 | -11,777 | -5,449 | 49,135 | 35,997 |
| Other Working Capital | -116,259 | -150,053 | -128,056 | -123,784 | -12,053 |
| Other Operating Activity | -146,471 | -614,315 | -328,529 | -205,141 | -252,460 |
| Operating Cash Flow | $984,125 | $402,176 | $606,008 | $743,434 | $850,103 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 30,974 | N/A | 4,821 |
| PPE Investments | -192,678 | -167,355 | -145,121 | -133,553 | -141,898 |
| Net Acquisitions | 28,435 | 1,163 | -1,136,158 | -1,550,291 | -15,588 |
| Purchase Of Investment | -3,110 | -1,890 | -2,438 | -292 | -2,250 |
| Purchase Sale Intangibles | -17,920 | -26,172 | -31,691 | -30,326 | -168,253 |
| Other Investing Activity | -17,920 | -26,172 | -31,692 | -30,327 | -168,253 |
| Investing Cash Flow | $-185,273 | $-194,254 | $-1,284,434 | $-1,714,462 | $-323,168 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -408,460 | 409,737 | 89,195 | 1,599,280 | 168,735 |
| Debt Repayment | N/A | -704,899 | N/A | N/A | N/A |
| Common Stock Issued | 3,999 | 72,700 | 1,309,816 | -17,350 | 49,174 |
| Common Stock Repurchased | N/A | N/A | N/A | -72,900 | -80,350 |
| Dividend Paid | -734,280 | -686,288 | -609,020 | -589,178 | -615,481 |
| Other Financing Activity | 370,546 | 688,033 | -34,990 | 41,116 | -32,461 |
| Financing Cash Flow | $-768,195 | $-220,717 | $755,001 | $960,968 | $-510,383 |
| Exchange Rate Effect | -7,257 | -4,507 | N/A | N/A | N/A |
| Beginning Cash Position | 116,703 | 132,459 | 59,368 | 65,318 | 51,906 |
| End Cash Position | 140,251 | 114,575 | 130,637 | 60,361 | 71,994 |
| Net Cash Flow | $23,548 | $-17,884 | $71,270 | $-4,957 | $20,088 |
| Free Cash Flow | |||||
| Operating Cash Flow | 984,125 | 402,176 | 606,008 | 743,434 | 850,103 |
| Capital Expenditure | -193,419 | -169,536 | -146,268 | -135,157 | -147,683 |
| Free Cash Flow | 790,706 | 232,640 | 459,740 | 608,278 | 702,420 |